Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J MacEwan

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Biochemical Pharmacology|November 26, 2020
Pharmacological impact of FLT3 mutations on receptor activity and responsiveness to tyrosine kinase inhibitorsVanessa Marensi, Karen R Keeshan, David J MacEwan
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 2011
TNF mediates the sustained activation of Nrf2 in human monocytesStuart A Rushworth, Suharsh Shah, David J MacEwan
The Biochemical Journal|June 6, 2003
Distinct regulation of cytosolic phospholipase A2 phosphorylation, translocation, proteolysis and activation by tumour necrosis factor-receptor subtypesOrla J Jupp, Peter Vandenabeele, David J MacEwan
Cell Cycle (Georgetown, Tex.)|March 16, 2011
Silencing FLIP(L) modifies TNF-induced apoptotic protein expressionLyubov Zaitseva, Stuart A Rushworth, David J MacEwan
British Journal of Pharmacology|February 26, 2021
The importance of Ras in drug resistance in cancerFiona M Healy, Ian A Prior, David J MacEwan
Cancer Research|January 8, 2011
High basal nuclear levels of Nrf2 in acute myeloid leukemia reduces sensitivity to proteasome inhibitorsStuart A Rushworth, Kristian M Bowles, David J MacEwan
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytesStuart A Rushworth, David J MacEwan, Maria A O'Connell
Cellular Signalling|October 8, 2011
Micro RNAs as a new therapeutic target towards leukaemia signallingMegan Y Murray, Stuart A Rushworth, David J MacEwan
The New England Journal of Medicine|September 27, 2013
Ibrutinib in relapsed chronic lymphocytic leukemiaStuart A Rushworth, David J MacEwan, Kristian M Bowles
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2007
Elevated NF-kappaB responses and FLIP levels in leukemic but not normal lymphocytes: reduction by salicylate allows TNF-induced apoptosisColin Rae, Susana Langa, Steven J Tucker, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Biochemical Pharmacology|November 26, 2020
Pharmacological impact of FLT3 mutations on receptor activity and responsiveness to tyrosine kinase inhibitorsVanessa Marensi, Karen R Keeshan, David J MacEwan
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 2011
TNF mediates the sustained activation of Nrf2 in human monocytesStuart A Rushworth, Suharsh Shah, David J MacEwan
The Biochemical Journal|June 6, 2003
Distinct regulation of cytosolic phospholipase A2 phosphorylation, translocation, proteolysis and activation by tumour necrosis factor-receptor subtypesOrla J Jupp, Peter Vandenabeele, David J MacEwan
Cell Cycle (Georgetown, Tex.)|March 16, 2011
Silencing FLIP(L) modifies TNF-induced apoptotic protein expressionLyubov Zaitseva, Stuart A Rushworth, David J MacEwan
British Journal of Pharmacology|February 26, 2021
The importance of Ras in drug resistance in cancerFiona M Healy, Ian A Prior, David J MacEwan
Cancer Research|January 8, 2011
High basal nuclear levels of Nrf2 in acute myeloid leukemia reduces sensitivity to proteasome inhibitorsStuart A Rushworth, Kristian M Bowles, David J MacEwan
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytesStuart A Rushworth, David J MacEwan, Maria A O'Connell
Cellular Signalling|October 8, 2011
Micro RNAs as a new therapeutic target towards leukaemia signallingMegan Y Murray, Stuart A Rushworth, David J MacEwan
The New England Journal of Medicine|September 27, 2013
Ibrutinib in relapsed chronic lymphocytic leukemiaStuart A Rushworth, David J MacEwan, Kristian M Bowles
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2007
Elevated NF-kappaB responses and FLIP levels in leukemic but not normal lymphocytes: reduction by salicylate allows TNF-induced apoptosisColin Rae, Susana Langa, Steven J Tucker, et al.
Pageof 6